Purchase Order HT001423P0174

Award Date 8/1/23
Potential Completion Date 7/31/24
Potential Value $41K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20889, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Health Agency awarded a $206,000.00 firm fixed price purchase order to the University of Maryland Medical System Corporation (UMMSC) to provide flow cytometry testing services. The contract has a completion date of February 4, 2026. UMMSC, a hospital and non-profit organization, will perform the services at its Bethesda, Maryland location. This contract is not associated with a set-aside program. UMMSC has previously received various federal contracts and grants from agencies such as...
<p>This is a firm fixed-price purchase order contract for $41,200.00 awarded by the Defense Health Agency (DHA) to the University of Maryland Medical System (UMMS), doing business as the University of Maryland Greenebaum Cancer Center. The contract is for flow cytometry testing services. UMMS is a non-profit healthcare system that has received previous prime federal contracts from agencies like the NIH, NIAID, and HHS for medical services. The contract does not have a set-aside designation.</p>
This is a $1,211,048 firm-fixed-price purchase order contract awarded to Sysmex America, Inc. by the U.S. Army Medical Command. The contract is for cost-per-test flow cytometry testing services, including the CDC basic panel, leukemia/lymphoma panel, and stem cell/CD34 testing. The contract will support testing requirements at the Brooke Army Medical Center in Fort Sam Houston, Texas. The original solicitation was a sources sought notice seeking vendors capable of providing a cost-per-test...
This is a delivery order awarded by the Department of Veterans Affairs (VA) to Becton, Dickinson and Company (BD), a manufacturer of medical devices, instruments, reagents, and related products. The contract is for cost-per-test flow cytometry services, with a ceiling value of $92,002.32 and a period of performance ending on December 11, 2020. There is no set-aside designation for this award. BD, through its BD Biosciences division, is a major provider of flow cytometry instruments, reagents,...
This is a firm fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Becton, Dickinson and Company (BD), a global medical technology company, for the provision of cost-per-test flow cytometry services. The contract has a ceiling value of $193,569.78 and was awarded on August 10, 2016, with an ultimate completion date of August 4, 2017. The order is not designated as a set-aside contract. BD, through its BD Biosciences division, is a major supplier of flow...
This federal contract award, valued at $23,835.01, was issued by the Defense Health Agency (DHA) to Becton, Dickinson and Company (BD), a global medical technology company. The award is for 0 FOR OTHER FUNCTIONS 26184901S FCB 2 BASIC FLOWCELL SRVC, which appears to be for the provision of flow cytometry services and consumables. The contract is a firm fixed price purchase order with a completion date of July 10, 2015. It is not designated as a set-aside contract. BD is a manufacturer of...
The U.S. Department of Defense Uniformed Services University of the Health Sciences awarded a $120,710.82 firm fixed price purchase order contract to Life Technologies Corporation, a for-profit manufacturer of scientific instruments, reagents, and consumables, for an ATTUNE NXT AFC BRV-LASER flow cytometer system. The contract has a completion date of October 31, 2018 and no set-aside designation was used. The original solicitation indicated the requirement was for the acquisition of a single...
This is a firm fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Becton, Dickinson and Company (BD) for cost per test flow cytometry services. The potential value of the contract is $175,676.35 and the performance period runs through September 30, 2019. BD is a global medical technology company that provides specialized instruments, reagents, and services for biomedical research and clinical applications, particularly in...
This federal contract award is for a Flow Cytometer Maintenance Agreement between the Uniformed Services University of the Health Sciences (USUHS), a defense agency, and Life Technologies Corporation, doing business as Thermo Fisher Scientific. The purchase order has a firm fixed price of $40,663.87 and a period of performance through March 9, 2025. No set-aside designation was used. Life Technologies Corporation, a prominent manufacturer of scientific instruments and reagents, is the prime...
This federal contract award is for FLOW CYTOMETRY REAGENTS AND SUPPLIES for the DC VAMC (Veterans Affairs Medical Center). The contract was awarded to Becton, Dickinson and Company (BD), a global medical technology company that provides instruments, reagents, and services for biomedical research and clinical applications, particularly in the area of flow cytometry. The contract is a $234,811.08 firm fixed price purchase order with a period of performance ending on June 30, 2023. It was awarded...

The Defense Health Agency (DHA), a component of the U.S. Department of Defense, awarded a $41,200 firm fixed price purchase order to the University of Maryland Medical System Corporation (UMMSC), located in Bethesda, Maryland, to provide flow cytometry testing services from August 1, 2023 through July 31, 2024. Flow cytometry is a technique used to detect and measure physical and chemical characteristics of particles or cells in suspension, allowing for analysis at the single-cell level. Under this contract, UMMSC will leverage its expertise in flow cytometry to analyze samples and provide testing results to support DHA programs over the one-year period of performance. No subcontractors or set-aside designations were identified.

Generated 12/24/23, 9:50 PM